Cobimetinib is an Oral MEK1 Inhibitor for Melanoma Research
MEK (Mitogen-activated protein kinase kinase, MAPKK) is a kinase enzyme that phosphorylates mitogen-activated protein kinases (MAPKs). Firstly, the activated MAPK leads to the phosphorylation of downstream transcription factors that regulate…